The midterm efficacy of hybrid ablation of atrial fibrillation (AF) reported in recent papers is about 70% in terms of sinus rhythm maintenance without antiarrhythmic drugs. Bearing in mind that the majority of patients enrolled are patients with persistent and long-standing persistent AF, the reported efficacies seem to be very good. Despite the high efficacies, safety remains a critical issue in hybrid, and especially thoracoscopic ablations. The frequency of complications during thoracoscopic ablations is more than 10% in the majority of reports. Most are short-term with no sequelae (such as pneumothorax or pneumonia); however, life-threatening complications have also been described, e.g., a sternotomy in response to a laceration of the left atrium (LA). One of the most serious ablation complications is stroke. The rate of strokes, which has been reported during or shortly after thoracoscopic ablation, seems to be higher than the rate reported after catheter ablation. This is especially true in papers describing thoracoscopic ablations that were not immediately followed by a catheter ablation. A possible explanation is differences in anticoagulation management during the two procedures. During catheter endocardial procedures, a standard anticoagulation protocol exists and is routinely applied; however, there is no such set of recommendations for anticoagulation during the thoracoscopic-phase of an ablation. It seems probable that, in many cases, no anticoagulation is used during thoracoscopic ablations. Moreover, whatever anticoagulation protocol is used during thoracoscopic ablations often goes unreported. A discussion about the best anticoagulation strategy during thoracoscopic ablation is urgently needed. In the future, standards of anticoagulation during thoracoscopic ablation should be clearly reported, just as they are now for catheter ablations.

Cardiocenter 3rd Faculty of Medicine Charles University Prague and University Hospital Kralovske Vinohrady Prague Czech Republic

Clinic of Cardiac Surgery University Hospital Kralovske Vinohrady Charles University Prague Czech Republic

Europace. 2017 Jan;19(1):58-65. doi: 10.1093/europace/euw026. PubMed

See more in PubMed

de Asmundis C, Chierchia GB, Mugnai G, et al. Midterm clinical outcomes of concomitant thoracoscopic epicardial and transcatheter endocardial ablation for persistent and long-standing persistent atrial fibrillation: a single-centre experience. Europace 2017;19:58-65. PubMed

Pison L, Gelsomino S, Lucà F, et al. Effectiveness and safety of simultaneous hybrid thoracoscopic and endocardial catheter ablation of lone atrial fibrillation. Ann Cardiothorac Surg 2014;3:38-44. PubMed PMC

On YK, Park KM, Jeong DS, et al. Electrophysiologic Results After Thoracoscopic Ablation for Chronic Atrial Fibrillation. Ann Thorac Surg 2015;100:1595-602; discussion 1602-3. 10.1016/j.athoracsur.2015.04.127 PubMed DOI

Bulava A, Mokracek A, Hanis J, et al. Sequential hybrid procedure for persistent atrial fibrillation. J Am Heart Assoc 2015;4:e001754. 10.1161/JAHA.114.001754 PubMed DOI PMC

Vroomen M, Pison L. Hybrid ablation for atrial fibrillation: a systematic review. J Interv Card Electrophysiol 2016;47:265-74. 10.1007/s10840-016-0183-9 PubMed DOI PMC

Boersma LV, Castella M, van Boven W, et al. Atrial fibrillation catheter ablation versus surgical ablation treatment (FAST): a 2-center randomized clinical trial. Circulation 2012;125:23-30. 10.1161/CIRCULATIONAHA.111.074047 PubMed DOI

Romanov A, Pokushalov E, Elesin D, et al. Effect of left atrial appendage excision on procedure outcome in patients with persistent atrial fibrillation undergoing surgical ablation. Heart Rhythm 2016;13:1803-9. 10.1016/j.hrthm.2016.05.012 PubMed DOI

Osmancik P, Budera P, Zdarska J, et al. Electrophysiological findings after surgical thoracoscopic atrial fibrillation ablation. Heart Rhythm 2016;13:1246-52. 10.1016/j.hrthm.2016.02.007 PubMed DOI

Probst J, Jidéus L, Blomström P, et al. Thoracoscopic epicardial left atrial ablation in symptomatic patients with atrial fibrillation. Europace 2016;18:1538-44. 10.1093/europace/euv438 PubMed DOI

Edgerton Z, Perini AP, Horton R, et al. Hybrid Procedure (Endo/Epicardial) versus Standard Manual Ablation in Patients Undergoing Ablation of Longstanding Persistent Atrial Fibrillation: Results from a Single Center. J Cardiovasc Electrophysiol 2016;27:524-30. 10.1111/jce.12926 PubMed DOI

Compier MG, Braun J, Tjon A, et al. Outcome of stand-alone thoracoscopic epicardial left atrial posterior box isolation with bipolar radiofrequency energy for longstanding persistent atrial fibrillation. Neth Heart J 2016;24:143-51. 10.1007/s12471-015-0785-3 PubMed DOI PMC

Khan IA. Atrial stunning: basics and clinical considerations. Int J Cardiol 2003;92:113-28. 10.1016/S0167-5273(03)00107-4 PubMed DOI

Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016;37:2893-962. 10.1093/eurheartj/ehw210 PubMed DOI

Badhwar V, Rankin JS, Damiano RJ, Jr, et al. The Society of Thoracic Surgeons 2017 Clinical Practice Guidelines for the Surgical Treatment of Atrial Fibrillation. Ann Thorac Surg 2017;103:329-41. 10.1016/j.athoracsur.2016.10.076 PubMed DOI